share_log

美股收盘:市场静待英伟达财报 三大指数小幅上涨 道指又创新高

US stocks closed: the market awaits NVIDIA's financial report, and the three major indexes rose slightly. The Dow once again hit a new high.

cls.cn ·  Aug 28 06:01

① The three major indices rose slightly, with the Dow hitting a new high; ② Large-cap tech stocks fluctuated, with Nvidia rising over 1%; ③ China concept stocks saw mixed performance, with XPeng rising over 6%.

On August 28th, Caixin reported (Editor: Xia Junxiong) that on Tuesday, the three major indices rose slightly, with the Dow edging up 0.02%, setting a new closing high again, while the S&P 500 index approached its historical high.

(Three major index minute chart, source: TradingView)

At the close, the Dow rose 0.02% to 41,250.50 points; the S&P 500 index rose 0.16% to 5,625.80 points; and the Nasdaq index rose 0.16% to 17,754.82 points.

Investors are eagerly awaiting Nvidia's earnings report, as it is a key indicator for the AI industry and even the entire technology sector. Investors will assess the state of the AI industry based on its latest performance.

Jim Reid, a strategist and analyst at Deutsche Bank, said that Nvidia's performance is attracting attention because the market reaction it has caused is comparable to that of employment or inflation reports.

Ross Mayfield, an analyst at Baird, pointed out that there is almost no important economic data before Nvidia's earnings report, so the market is in a wait-and-see mode.

AI server manufacturer Super Micro Computer's stock price fell 2.64% on Tuesday, and at one point during the trading day, it dropped by over 8%. Well-known short-selling institution Muddy Waters released a short report on the company on Tuesday.

Popular stocks performance

Large technology stocks showed mixed performances, with Apple up 0.37%, Microsoft up 0.08%, Nvidia up 1.46%, Tesla down 1.88%, Google down 0.89%, Amazon down 1.36%, Meta down 0.39%.

China concept stocks experienced varied movements, with the Nasdaq Golden Dragon Index up 0.39%, Alibaba down 0.38%, JD.com up 2.25%, PDD Holdings down 4.09%, Nio Inc. down 0.74%, Xpeng up 6.52%, Li Auto Inc. up 2.36%, Bilibili up 1.47%, Baidu down 1.62%, Netease up 1.26%, Tencent Music up 0.28%, iQiyi down 2.38%.

Company news

OpenAI may launch its reasoning AI product 'Strawberry' as early as this autumn.

As OpenAI raises more funds, its researchers are attempting to launch a new AI product, with the goal of introducing an AI product with the codename 'Strawberry' as early as this autumn, possibly as part of ChatGPT. Researchers involved in this work stated that 'Strawberry' can solve mathematical problems that chatbots have never encountered before and can also be trained to solve programming-related problems.

KLM Royal Dutch Airlines: No longer using aircraft produced by Boeing.

On August 27th local time, KLM Royal Dutch Airlines received its first 'Airbus' aircraft for short-haul flights. The company stated that in the coming years, KLM Royal Dutch Airlines will invest 7 billion euros in a new fleet and will no longer use Boeing aircraft. It is understood that the company plans to use the Airbus A321neo aircraft to replace the existing Boeing 737 and the Airbus A350 for long-haul flights to replace the current Boeing aircraft.

The board of directors of the car rental company Hertz has added two new members, increasing the total number of board members to 11.

The US car rental company Hertz announced on Tuesday that Francis Blake and Lucy Clark Dougherty have been elected as board members, increasing the total number of board members from 9 to 11. Due to weak demand, Hertz has been scaling back its operations and clearing its electric cars after maintenance and overall fleet maintenance costs exceeded expectations.

The planned new data center of Google Ireland has been rejected by the local council in South County Dublin, citing 'insufficient grid capacity' as the reason.

The South Dublin County Council in Ireland recently refused to grant planning permission to Google Ireland for the construction of a new data center in the Grange Castle Business Park in the south of Dublin, citing reasons such as 'insufficient existing grid capacity' and 'lack of a substantial amount of renewable energy sources on site to power the data center'.

The council also stated that Google did not provide sufficient detailed information on 'how the proposed project will affect the power supply after its commissioning in 2027'. This plan is the third phase of the Google Ireland data center campus, involving the creation of 800 construction jobs, and will create 50 jobs after commissioning. According to data from the Central Statistics Office of Ireland, the electricity consumption of data centers accounted for approximately 21% of the total national electricity consumption in Ireland last year, compared to only 5% in 2015. It is estimated that by 2028, this figure will reach 27%.

On Tuesday (August 27th) local time, Eli Lilly and Company announced on its official website that a smaller-dose version of Zypbound (lanreotide injection) has been launched in the United States and patients can purchase it on Lilly's self-operated website 'LillyDirect'.

On Tuesday (August 27th), local time, Eli Lilly and Company announced on its official website that a smaller-dose version of Zypbound (lanreotide injection) has been launched in the United States and patients can purchase it on Lilly's self-operated website 'LillyDirect'.

There are six doses of Zepbound (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) available for patients to gradually increase the dosage. Previously, regardless of the dosage, the price of the injection course for four weeks of use was $1059.87 (approximately 7553 RMB).

According to Eli Lilly's latest pricing, the price of a single dose of 2.5 mg, a course of treatment for four weeks of use, is $399 ($99.75 per bottle); the 5 mg version is priced at $549 ($137.25 per bottle), which is close to a discount of 50% compared to the original price.

Eli Lilly stated that this move can help the company expand the supply of Zepbound and meet the high demand in the market. At the same time, this new option can help millions of obese adults who are not covered by U.S. health insurance to obtain the necessary medication.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment